Products
NEWS DETAILS
Home
>
News
>

Efficient synthesis and anticancer evaluation of spider toxin peptide LVTX-8-based analogues with enhanced stability

Efficient synthesis and anticancer evaluation of spider toxin peptide LVTX-8-based analogues with enhanced stability

2023-07-06

Latest company news about Efficient synthesis and anticancer evaluation of spider toxin peptide LVTX-8-based analogues with enhanced stability

The final concentrations of peptides were set according to their IC50 values: LTX-315 (synthesized and provided by KS-V Peptide Biological Technology Co., Ltd., Hefei, China) 10 μM, 827 2.5 μM, MTX 100 μM, and other peptides 1 μM.

Publisher: Qingdao University of Science and Technology

Publication: Bioorganic Chemistry

Acknowledgment of KS-V Peptide Products: Scientific Research Peptides